Tryp to initiate psilocybin-assisted psychotherapy trial to treat IBS

Tryp Therapeutics has announced plans to initiate a Phase IIa clinical trial of psilocybin-assisted psychotherapy for the treatment of irritable bowel syndrome (IBS) at Massachusetts General Hospital (MGH) in the US.